By Nancy Lapid (Reuters) -Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the ...

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

As the popularity of weight-loss drugs surges, a new concern is emerging: “Ozempic teeth.” The term refers to a range of dental issues users have reportedly been experiencing — such as dry mouth, bad ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Speaking previously to E! News, Sharon claimed that, at her heaviest, she'd weighed over 230 pounds. She added at the time ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...